Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 676 of 767

Advanced search

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults

Psychiatric TimesOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

US FDA declines to approve Achieve Life Sciences' smoking-cessation drug

ReutersOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned

BenzingaOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Beyond the Biotech Race — Right-Sizing U.S.-China Competition in a Human-Centered Industry

Asia SocietyOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Engineers test, validate novel method to improve pharmaceutical research and development

Medical XpressOriginal source

🇺🇰Jun 22Regulatorygov.ukTier 1 · Regulatory source

DHSC: spending over £500, May 2026

Department of Health and Social Care spending by electronic purchasing card solution (ePCS), over £5...

UK Department of Health and Social CareOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

White Paper: The NDC-12 Revenue Risk

Pharmaceutical CommerceOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

FDA backs Entera Bio’s 750-patient osteoporosis trial for EB613

Stock TitanOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Leaf4Life Engages Phase Advance To Predict Clinical Outcomes for 16 Phase 3 Trials

EIN NewsOriginal source

🇺🇰Jun 22Regulatorygov.ukTier 1 · Regulatory source

UKHSA privacy notice

This privacy notice explains the personal information we collect, how we use it and who we may share...

UK Health Security AgencyOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

FDA Announces Recall of Common Blood Pressure Medication

Health: Trusted and Empathetic Health and Wellness InformationOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

FDA Launches New Pilot to Speed Early-Stage Drug Development

Bloomberg Law NewsOriginal source

🇯🇵Jun 22Researchriken.jpTier 2 · Direct publisher

RIKEN’s new AI for Science supercomputer has an official name: "RIKYU"

RIKENOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Merck reports positive Phase 3 tulisokibart results

grafa.comOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

AbbVie deepens immunology legacy in $10.9bn Apogee buyout

Pharmaceutical TechnologyOriginal source

🇺🇰Jun 22Regulatorygov.ukTier 1 · Regulatory source

Letter to Baroness Casey: progress on adult social care reform recommendations

The Secretary of State for Health and Social Care updates Baroness Casey of Blackstock on progress a...

UK Department of Health and Social CareOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Achieve Life Sciences receives FDA rejection on manufacturing issues

Investing.com UKOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Here's Why You Should Add LXRX Stock to Your Portfolio Now

TradingViewOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial

BioSpaceOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

Merck’s IBD drug from $10.8B Prometheus deal claims its first Phase 3 win

Endpoints NewsOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

FDA Cites Manufacturing Issues for Cytisinicline

ConexiantOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

US to investigate Germany's proposed drug spending reforms

Fierce PharmaOriginal source

🌍Jun 22Industrysinopharmtech.comTier 1 · Company source

Sinopharmtech at CPHI & PMEC China 2026 Expo

Sinopharm TechOriginal source

🇺🇰Jun 22Regulatorygov.ukTier 1 · Regulatory source

Vaccine update: issue 371, May 2026, NIN special

Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.

UK Health Security AgencyOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Purdue engineers test, validate novel method to improve pharmaceutical R&D

Purdue UniversityOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

America is losing ground to China in clinical research and medical innovation

HarianBasis.coOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Offworld Biotech: Installing NEMUCO In BioLab On The International Space Station

astrobiology.comOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

AbbVie seals $10.9B deal to acquire Waltham biotech Apogee Therapeutics

The Business JournalsOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

Another big deal, another sign biotech M&A is back

statnews.comOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Creative Medical gets FDA clearance to add 15 patients in Olastrocel trial

Stock TitanOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Marius Pharmaceuticals Applauds FDA’s Proposed Testosterone Labeling Updates as a Turning Point for Men’s Health

The Manila TimesOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Nuvectis Expands Pipeline with Haisco Licensing Agreement for Two Clinical-Stage Drug Candidates (NVCT)

Yahoo FinanceOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Poll: What's causing the spike in weight-loss drug mistakes?

MSNOriginal source

🇪🇺Jun 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: The natural K, Fe, and Cu isotopic response to Pt-based chemotherapeutic drug resistance in ovarian cancer

CORDISOriginal source

🇪🇺Jun 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: TraffikGene-Tx: Targeted Peptide Carriers for RNA Delivery

CORDISOriginal source

🇪🇺Jun 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Miniaturized plasma emission spectroscopy-based breath analysis for unobtrusive at-home monitoring and prediction of COPD exacerbations

CORDISOriginal source

🇪🇺Jun 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic cardiomyopathy diagnosis and treatment

CORDISOriginal source

🇪🇺Jun 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

CORDISOriginal source

🇺🇰Jun 22Regulatorygov.ukTier 1 · Regulatory source

DHSC one-off statistical releases

A list of one-off statistical releases published by the Department of Health and Social Care (DHSC).

UK Department of Health and Social CareOriginal source

🇪🇺Jun 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment

CORDISOriginal source

🇺🇰Jun 22Regulatorygov.ukTier 1 · Regulatory source

Estimated impact of the introduction of the single patient record

Methodology behind the estimated figures for financial and clinical hours saved, and A&E and hospita...

UK Department of Health and Social CareOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Achieve Life FDA rejects cytisinicline filing over manufacturing issues

Stock TitanOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

GlobeNewswireOriginal source

🇪🇺Jun 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: FCAECC Fellowship programme for talented researchers in cancer

CORDISOriginal source

🇪🇺Jun 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Next-generation models and genetic therapies for rare neuromuscular diseases

CORDISOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Verrica starts Phase 3 common-warts trial with first U.S. patient

Stock TitanOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Verrica Pharmaceuticals Announces First U.S. Patient Dosed

GlobeNewswireOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

Insilico’s AI design engine bags deal with Korean biotech worth possible $2.5B+

BioSpaceOriginal source

🇨🇦Jun 22Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Penumbra System RED 68 Reperfusion Catheter

Penumbra has identified an issue in the lots of RED 68 specified in this notification which may resu...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jun 22Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Gyrus ACMI® Classic Series Continuous Flow Resectoscope

This recall action is being taken because it has been determined that some of the sets of sterilizat...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

AbbVie inks $10.9B Apogee buyout to bag eczema prospect

Fierce BiotechOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Insmed: Extensive Phase 3 TPIP Program And Revenue Growth In Q1 2026, Strong Buy

Seeking AlphaOriginal source

🇺🇰Jun 22Regulatorygov.ukTier 1 · Regulatory source

COVID-19 vaccination: spring 2026 campaign resources

Information on the spring 2026 campaign for eligible individuals.

UK Health Security AgencyOriginal source

🇺🇰Jun 22Regulatorygov.ukTier 1 · Regulatory source

UK Public Health Rapid Support Team (UK-PHRST)

The UK-PHRST is a UK aid-funded project operated by UK Health Security Agency (UKHSA) and the London...

UK Department of Health and Social CareOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

Definium LSD therapy helped patients with major depression in late-stage trial

statnews.comOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

MoonLake (MLTX) reveals robust Phase 3 HS data and targets 2026 BLA filing

Stock TitanOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says

Fierce BiotechOriginal source

🌍Jun 22discoverynews.google.comTier 3 · Aggregated media

Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

Business WireOriginal source

🌍Jun 22discoverynews.google.comTier 2 · Trade media

Helmed by Sanofi vet, Bionyra emerges with $165M and three licensed I&I assets

Fierce BiotechOriginal source

🇺🇸Jun 22CROir.labcorp.comTier 3 · Secondary coverage

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

Labcorp Drug DevelopmentOriginal source